Literature DB >> 9126325

Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells.

L Jiang1, F M Foster, P Ward, V Tasevski, B M Luttrell, A D Conigrave.   

Abstract

Extracellular ATP and ATP gamma S (1-1000 microM) stimulated cyclic AMP (cAMP) production in undifferentiated HL-60 cells. The potency order for adenine nucleotides and adenosine was ATP gamma S > ATP > > ADP > 3 AMP = Adenosine. Indomethacin (50 microM) had no effect on ATP-induced cAMP production. ATP and ATP gamma S also suppressed cell growth and induced differentiation as revealed by fMLP-stimulated beta-glucuronidase release 48 h after exposure. The potency order for the induction of fMLP-stimulated beta-glucuronidase release by adenine nucleotides and adenosine was ATP gamma S > 3 ATP > ADP > AMP = Adenosine approximately 0. The protein kinase A inhibitor Rp-8-Br-cAMPS (10-200 mM) suppressed ATP-induced differentiation but had no effect on ATP-dependent growth suppression. UTP which, like ATP, activates P2U receptors on HL-60 cells, had no effect on cAMP production, cell growth, or differentiation. The data suggest the existence of a novel receptor for ATP on undifferentiated HL-60 cells that is coupled to the activation of adenylate cyclase and cAMP-dependent differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126325     DOI: 10.1006/bbrc.1997.6345

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 2.  A critical look at the function of the P2Y11 receptor.

Authors:  Karin Dreisig; Birgitte Rahbek Kornum
Journal:  Purinergic Signal       Date:  2016-05-31       Impact factor: 3.765

3.  Pharmacological characterization of the human P2Y11 receptor.

Authors:  D Communi; B Robaye; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 4.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

Review 5.  Cyclic nucleotides and phosphodiesterases in monocytic differentiation.

Authors:  Angie L Hertz; Joseph A Beavo
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines.

Authors:  L van der Weyden; D J Adams; B M Luttrell; A D Conigrave; M B Morris
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

7.  Connexin Hemichannels Contribute to the Activation of cAMP Signaling Pathway and Renin Production.

Authors:  Jingru Hong; Jian Yao
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.